Journal
DIABETES CARE
Volume 42, Issue 3, Pages 416-426Publisher
AMER DIABETES ASSOC
DOI: 10.2337/dc17-1144
Keywords
-
Categories
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23-DK-092783]
- American Diabetes Association [1-18-JDF-037]
- University of Chicago Bucksbaum Institute for Clinical Excellence
- NIDDK [K24-DK-105340]
- NIDDK- Diabetes Aging Study [R01-DK-081796, R56-AG-051683]
Ask authors/readers for more resources
OBJECTIVE To examine for a legacy effect of early glycemic control on diabetic complications and death. RESEARCH DESIGN AND METHODS This cohort study of managed care patients with newly diagnosed type 2 diabetes and 10 years of survival (1997-2013, average follow-up 13.0 years, N = 34,737) examined associations between HbA(1c) <6.5% (<48 mmol/mol), 6.5% to <7.0% (48 to <53 mmol/mol), 7.0% to <8.0% (53 to <64 mmol/mol), 8.0% to <9.0% (64 to <75 mmol/mol), or >= 9.0% (>= 75 mmol/mol) for various periods of early exposure (0-1, 0-2, 0-3, 0-4, 0-5, 0-6, and 0-7 years) and incident future microvascular (end-stage renal disease, advanced eye disease, amputation) and macrovascular (stroke, heart disease/failure, vascular disease) events and death, adjusting for demographics, risk factors, comorbidities, and later HbA(1c). RESULTS Compared with HbA(1c) <6.5% (<48 mmol/mol) for the 0-to-1-year early exposure period, HbA(1c) levels >= 6.5% (>= 48 mmol/mol) were associated with increased microvascular and macrovascular events (e.g., HbA(1c) 6.5% to <7.0% [48 to <53 mmol/mol] microvascular: hazard ratio 1.204 [95% CI 1.063-1.365]), and HbA(1c) levels >= 7.0% (>= 53 mmol/mol) were associated with increased mortality (e.g., HbA(1c) 7.0% to <8.0% [53 to <64 mmol/mol]: 1.290 [1.104-1.507]). Longer periods of exposure to HbA(1c) levels >= 8.0% (>= 64 mmol/mol) were associated with increasing microvascular event and mortality risk. CONCLUSIONS Among patients with newly diagnosed diabetes and 10 years of survival, HbA(1c) levels >= 6.5% (>= 48 mmol/mol) for the 1st year after diagnosis were associated with worse outcomes. Immediate, intensive treatment for newly diagnosed patients may be necessary to avoid irremediable long-term risk for diabetic complications and mortality.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available